The association between 4-HNE accumulation, as well as GPX4 and FSP1 expression, and cancer has been investigated in various cancers, including gastric cancer and hepatocellular carcinoma, and has attracted attention as a potential new therapeutic strategy [5,6,7,8]. Here, GPX4 is linked to hepatocellular carcinoma.